Brent McLaurin - Concepedia

Author

Brent McLaurin

Cardiovascular Research Foundation ORCID

Also Known As

B. McLaurin, B.T. McLaurin, BRENT MCLAURIN, Brent McLaurin, Brent Mclaurin, Brent T McLaurin, Brent T. McLaurin, Hugh McIntyre, Peter Kuhlman, Ramon Horacio Limon Rodriguez

Publications

6.2K

Citations

H-Index

Concepts

All Affiliations

Cardiovascular Research Foundation Columbia University Irving Medical Center AnMed Health Cleveland Clinic Auckland City Hospital

About

Brent McLaurin is an author at Cardiovascular Research Foundation specializing in medicine, cardiovascular disease, and coronary heart disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	2.3K
2	Public Health	7	7	969
3	Emergency Medicine	5	5	1.1K
4	Biomedical Engineering	1	1	38
5	Diabetes	1	1	50

Brent McLaurin

Publications

5.9K

Citations

H-Index

Page 1

	Year	Citations
Bivalirudin for Patients with Acute Coronary Syndromes Gregg W. Stone, Brent McLaurin, David A. Cox, New England Journal of Medicine	2006	1.4K
Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events Deepak L. Bhatt, Gregg W. Stone, Kenneth W. Mahaffey, New England Journal of Medicine	2013	818
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial Michael Böhm, Kazuomi Kario, David E. Kandzari, The Lancet Antihypertensive MedicationsHypertensionUrologyRenal FunctionAntihypertensive Therapy	2020	555
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial Gregg W. Stone, Harvey D. White, E. Magnus Ohman, The Lancet Percutaneous Coronary InterventionCardiovascular DiseasePatient SafetyAcute CatheterizationSubgroup Analysis	2007	391
Routine Upstream Initiation vs Deferred Selective Use of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes Gregg W. Stone, Michel E. Bertrand, Jeffrey W. Moses, JAMA	2007	302
The Changing Landscape for Stroke Prevention in AF Menno V. Huisman, Kenneth J. Rothman, Miney Paquette, Journal of the American College of Cardiology	2017	276
A Randomized Comparison of the Endeavor Zotarolimus-Eluting Stent Versus the TAXUS Paclitaxel-Eluting Stent in De Novo Native Coronary Lesions Martin B. Leon, Laura Mauri, Jeffrey J. Popma, Journal of the American College of Cardiology Percutaneous Coronary InterventionCardiovascular DiseaseTaxus Paclitaxel-eluting StentLumen-apposing Metal StentCardiology	2010	240
Antithrombotic Strategies in Patients With Acute Coronary Syndromes Undergoing Early Invasive Management Gregg W. Stone, James H. Ware, Michel E. Bertrand, JAMA PharmacotherapyComposite IschemiaCoronary Artery DiseaseAcute Myocardial InfarctionThrombosis	2007	237
Prognostic Significance of Periprocedural Versus Spontaneously Occurring Myocardial Infarction After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes Abhiram Prasad, Bernard J. Gersh, Michel E. Bertrand, Journal of the American College of Cardiology ThrombosisPercutaneous Coronary InterventionCardiogenic ShockCardiovascular DiseaseCardiology	2009	195
Gastrointestinal Bleeding in Patients With Acute Coronary Syndromes: Incidence, Predictors, and Clinical Implications Eugenia Nikolsky, Gregg W. Stone, Ajay J. Kirtane, Journal of the American College of Cardiology Gastrointestinal BleedingThrombosisClinical ImplicationsCardiovascular DiseaseClinical Epidemiology	2009	189

Page 1